drugset / Trial / NCT04121767
Safety and Efficacy of Edoxaban in Thoracoscopic Ablation
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to compare the safety and efficacy of edoxaban and warfarin for prevention of stroke during a 6-month follow up after total thoracoscopic ablation.
Timeline
- Start
- 2017-12-01
- Primary completion
- 2020-06-30
- Completion
- 2020-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edoxaban | Small molecule | 60 mg | Oral |
| Comparator | Warfarin | Small molecule | — | Oral |